RESPONSE BIOMEDICAL CORP Proceeds from Stock Options Exercised
RESPONSE BIOMEDICAL CORP reported Proceeds from Stock Options Exercised of CAD 324 for the 12-month period ending 2010-12-31, per its 10-K filed 2013-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2013-03-15
- RESPONSE BIOMEDICAL CORP proceeds from stock options exercised for fiscal 2010 was 324.00 CAD.
| Period end | Proceeds from Stock Options Exercised 12 month |
|---|---|
| 2010-12-31 | 324.00 CAD 10-K · filed 2013-03-15 |